In a groundbreaking move, the U.S. Food and Drug Administration on June 23 issued draft guidance for clinical trials into psychedelic drugs. Read More

The Senate Majority leader is pulling out the stops to get the SAFE Act through Congress, and he recently expressed optimism it will pass. Read More

In another sign of the cultural shift on marijuana, a new poll shows that most Americans think alcohol, cigarettes, and opioids are riskier. Read More

Highly potent marijuana edibles are surging in popularity and altering the landscape for ganja-preneurs. Here’s what it means for investors. Read More

Here’s how Nixon's failed War on Drugs and the psychedelic subculture of the 1960s are reverberating on present-day Wall Street. Read More

Legislation introduced in Congress this week aims to accelerate the mainstreaming of hemp, the versatile botanical cousin to marijuana. Read More

In a legal watershed last week, a California bill to legalize the possession and use of psychedelics passed the state Senate. Read More

A new study by the American Medical Association found that marijuana is significantly effective in treating various physical ailments. Read More

The burgeoning marijuana industry is undoubtedly a good investment, but you need to pinpoint the right equities. Here are the criteria. Read More

At an annual cannabis festival on May 6 in New York City, U.S. Sen. Chuck Schumer (D-NY) gave new impetus to marijuana reform. Read More